VerImmune is an immune oncology company focused on redirecting pre-existing memory from past infecti
Location: United States, Maryland, Baltimore
Employees: 1-10
Total raised: $5.6M
Founded date: 2019
Investors 1
| Date | Name | Website |
| - | SeedFolio | seedfolio.... |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 25.09.2023 | - | $3.1M | - | technical.... |
| 05.08.2022 | Seed | $2.5M | - | finsmes.co... |
Mentions in press and media 10
| Date | Title | Description | Source |
| 25.09.2023 | Biotech startup VerImmune just raised $3.1M for its cancer t... | In a follow-on round, a local biotech company raised millions to help with the development of its ca... | technical.... |
| 20.09.2023 | VerImmune Raises Over $3M in Additional Funding | VerImmune, Inc., a Washington, DC-based early-stage biotechnology company specializing in the develo... | finsmes.co... |
| 20.02.2023 | VerImmune, Inc. Announces Issuance of Second U.S Patent Prot... | WASHINGTON (PRWEB) February 20, 2023 VerImmune, Inc. (“VerImmune”), a biotechnology company leading... | prweb.com/... |
| 13.10.2022 | Baltimore’s VC slowdown arrived in Q3 — and may mark a retur... | Editor’s note: These figures may vary slightly, as some deals aren’t accounted for until weeks after... | technical.... |
| 11.08.2022 | VerImmune accepted into the Nanotechnology Characterization ... | WASHINGTON (PRWEB) August 11, 2022 VerImmune, Inc. (“VerImmune”), a biotechnology company developin... | prweb.com/... |
| 29.07.2022 | VerImmune Closes USD2.5M in Seed Financing | Verlmmune, a Washington, DC-based biotechnology company developing therapeutic modalities that aim t... | finsmes.co... |
| 28.07.2022 | VerImmune Closes $2.5M Seed Financing | WASHINGTON, DC, VerImmune, a biotechnology company, announced the close of $2.5 million in Seed fu... | vcnewsdail... |
| 27.07.2022 | VerImmune Inc Announces Closing of Seed Financing to Further... | WASHINGTON, D.C. (PRWEB) July 27, 2022 VerImmune, Inc. (“VerImmune”), a biotechnology company devel... | prweb.com/... |
| 20.05.2022 | VerImmune and Fosun Pharma enter into an Exclusive License a... | WASHINGTON (PRWEB) May 20, 2022 VerImmune Inc. (“VerImmune”), a privately-held biotechnology compan... | prweb.com/... |
| 04.04.2022 | VerImmune, Inc. Announces Issuance of U.S Patent Protecting ... | WASHINGTON (PRWEB) April 04, 2022 VerImmune, Inc. (“VerImmune”), a biotechnology company developing... | prweb.com/... |